Primary IGF-1 Deficiency Medications
Drugs (by generic name) associated with Primary IGF-1 Deficiency
The following drugs and medications are in some way related to, or used in the treatment of Primary IGF-1 Deficiency. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
| Drug Name |
Reviews | Ratings |
||
|---|---|---|---|---|
| mecasermin systemic (Pro, More...) | 0 review(s) | Not rated - Be the first | ||
| mecasermin rinfabate systemic (More...) | 0 review(s) | Not rated - Be the first | ||
Latest Primary IGF-1 Deficiency Blog Post
Tercica Announces Results from Increlex Phase IIIb Study Demonstrating Dose-Dependent Height Velocity Increase in Primary IGFD Short Stature Population and Other Increlex Studies at the 13th International Congress of Endocrinology Meeting
BRISBANE, Calif.--(BUSINESS WIRE)--Nov 12, 2008 - Tercica, Inc., a wholly-owned subsidiary of Ipsen (Euronext: IPN) today announced Phase IIIb clinical trial results demonstrating that Increlex(R) (mecasermin (rDNA origin) injection) achieved statistically...
View all Primary IGF-1 Deficiency blog posts.
